Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
Steven A Cowman1,2, Joseph Jacob1,3, David M Hansell1,3
11 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
American Journal of Respiratory Cell and Molecular Biology
|December 6, 2017
Summary
Pulmonary nontuberculous mycobacterial (pNTM) disease involves an aberrant immune response, with reduced T cell signaling linked to severity. Immune cell function impacts survival outcomes in patients with pNTM disease.
Area of Science:
- Immunology
- Pulmonary Medicine
- Genomics
Background:
- Factors influencing pulmonary nontuberculous mycobacterial (pNTM) disease development and progression are not fully understood.
- Existing data on impaired immune responses in pNTM disease are limited and inconsistent.
Purpose of the Study:
- To investigate the host immune response in pNTM disease using gene expression profiling.
- To correlate gene expression patterns with clinical phenotypes and survival data.
Main Methods:
- Microarray analysis of whole-blood gene expression in 25 pNTM disease patients and 27 controls.
- Comparison of gene expression data with computed tomography (CT) findings, lung function, and survival.
Main Results:
- pNTM disease showed downregulation of transcripts related to T cell signaling, including interferon-gamma (IFNG).
- Reduced IFNG expression correlated with more severe CT changes and poorer lung function.
- Distinct immune response profiles were associated with survival (T and B cell function) and mortality (innate immunity and inflammation).
Conclusions:
- pNTM disease is characterized by an aberrant immune response, potentially predisposing to infection or resulting from it.
- Immune response pathways significantly differ between survivors and non-survivors of pNTM disease.
Related Concept Videos
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis V
655
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
655
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis IV
556
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
556
Pneumonia II: Pathophysiology
3.2K
The pathophysiology of pneumonia involves the following steps:
3.2K


